![1327-4_CareTeamEvolutionDataBriefIIA_FeatureGraphic.jpg](https://surescripts.widen.net/content/70dce6e1-c77f-411a-b090-465ea2d9159a/web/1327-4_CareTeamEvolutionDataBriefIIA_FeatureGraphic.jpg)
Cecelia Byers, Pharm.D.
Cecelia brings clinical expertise to Surescripts as a Specialty Clinical Product Advisor. As a pharmacist, Cecelia has a passion for patient care and uses that…
Bonnie Radintz
Bonnie Radintz leads the Integration, Customer Success and Education Services teams at Surescripts. She has spent more than 20 years streamlining and…
Bobby Davis
Bobby Davis is a Vice President of Key Accounts for Surescripts, with a primary focus of directly managing the relationships of strategic accounts within the…
Ashley Fifield
Ashley Fifield has worked in the healthcare industry for more than 10 years, and has primarily focused on health information technology in hospitals and…
Andrew Mellin, MD
Dr. Andrew Mellin is the Chief Medical Information Officer at Surescripts. Since joining in 2018, his tenure is marked by advancing strategic healthcare IT…
Judy Hatchett
Judy Hatchett sets the vision, develops plans and oversees execution of Surescripts’ Enterprise Information and Physical Security, Business Continuity and Risk…
Patricia Krause
Tricia is responsible for product planning and execution for Surescripts E-Prescribing. She has worked in healthcare for nearly 20 years, having spent time as…
Andrea Douglas
Andrea Douglas is an expert in pharmaceutical market access and reimbursement, including value- based contracting. Andrea’s background in public policy and…
Recipe for Affordability: One Dash Biosimilar, One Pinch Health IT
Biosimilars have come to market. The FDA has given the green light to 40 biosimilars as of December 2022, and there are more to come. This could mean better…